The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC cut its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 6.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 107,431 shares of the medical device company's stock after selling 7,932 shares during the period. Nisa Investment Advisors LLC owned 0.05% of Cooper Companies worth $9,062,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. City Holding Co. acquired a new position in Cooper Companies during the first quarter worth $34,000. New Age Alpha Advisors LLC purchased a new stake in Cooper Companies during the 4th quarter worth about $38,000. Covestor Ltd increased its holdings in Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after purchasing an additional 120 shares during the period. Atala Financial Inc acquired a new position in shares of Cooper Companies during the 4th quarter worth about $51,000. Finally, HM Payson & Co. boosted its position in shares of Cooper Companies by 147.4% during the 1st quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock worth $75,000 after acquiring an additional 532 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on COO shares. UBS Group raised Cooper Companies to a "buy" rating in a research report on Tuesday, June 17th. Robert W. Baird cut their target price on Cooper Companies from $107.00 to $97.00 and set an "outperform" rating for the company in a research note on Friday, May 30th. Wells Fargo & Company cut their target price on Cooper Companies from $118.00 to $93.00 and set an "overweight" rating for the company in a research note on Friday, May 30th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $76.00 price objective (down from $110.00) on shares of Cooper Companies in a research note on Friday, May 30th. Finally, Wall Street Zen upgraded Cooper Companies from a "hold" rating to a "buy" rating in a report on Friday, June 27th. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, Cooper Companies has an average rating of "Moderate Buy" and an average target price of $99.70.

Cooper Companies Trading Down 2.5%

Cooper Companies stock traded down $1.93 during midday trading on Friday, reaching $74.77. The stock had a trading volume of 2,517,933 shares, compared to its average volume of 1,741,694. The Cooper Companies, Inc. has a twelve month low of $65.00 and a twelve month high of $112.38. The stock has a market capitalization of $14.95 billion, a PE ratio of 36.30, a price-to-earnings-growth ratio of 1.87 and a beta of 0.99. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.23 and a current ratio of 2.10. The stock's 50-day simple moving average is $75.07 and its 200 day simple moving average is $82.84.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, beating the consensus estimate of $0.93 by $0.03. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The company had revenue of $1 billion for the quarter, compared to analyst estimates of $995.12 million. During the same period last year, the company posted $0.85 earnings per share. The firm's revenue was up 6.3% compared to the same quarter last year. Analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.